ResMed's Sales and Profits Rise
ResMed (NYSE: RMD), a medical device marker focused on continuous positive airway pressure (CPAP) machines and accessories, reported its fiscal first-quarter results on Thursday, Oct. 26. The company's top and bottom lines once again moved in the right direction and compared favorably to what market watchers had predicted. Investors applauded the company's success.
Image source: Getty Images.
Metric
Source: Fool.com
Resmed Inc. Aktie
203,50 €
2,31 %
Rein positive Einschätzungen für Resmed Inc., nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein positives Kurspotenzial für Resmed Inc. ist gegeben, mit einem Kursziel von 215 € über dem aktuellen Kurs von 203.5 €.
